Shoulder Innovations

Shoulder Innovations EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of Shoulder Innovations (SI) as of Nov 2, 2026 is -6.08. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was -21.07 — a change of -71.16% (higher).

EV/EBITDA

-6.08

YoY

-71.16%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of Shoulder Innovations is 2025 -6.08 . EV/EBITDA (Enterprise Value to EBITDA) of Shoulder Innovations was 2024 -21.07 . It decreases by -71.16% higher compared to the previous year.

The Shoulder Innovations EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2023
-26.33 USD
Jan 1, 2024
-21.07 USD
Jan 1, 2025
-6.08 USD
The Shoulder Innovations EV/EBITDA history
YEAREV/EBITDAYoY
-6.08-71.16%
-21.07-19.98%
-26.33—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shoulder Innovations Stock analysis

What does Shoulder Innovations do? Shoulder Innovations Inc generates revenue through its advanced implant systems for shoulder arthroplasty, specifically the aTSA and rTSA systems, which address patient and surgeon needs with customizable configurations for anatomic or reverse procedures. The company's ecosystem includes enabling technologies, instrument systems, specialized support, and surgeon-to-surgeon collaboration, enhancing preoperative planning, implant design, and procedural efficiency across the care chain. Its InSet Glenoid technology forms the foundational element of these systems, supporting comprehensive surgical solutions for healthcare providers. The firm targets hospitals and surgical centers as primary buyers, leveraging its commercial-stage medical technology focus to serve the shoulder surgical care market. The company's product portfolio centers on aTSA and rTSA systems, designed to improve core components of shoulder surgical care, with InSet Glenoid as the cornerstone of its implant solutions. These systems are sold to healthcare institutions seeking advanced surgical tools that streamline procedures and improve patient outcomes. Shoulder Innovations Inc capitalizes on its ecosystem approach, bundling implant systems with enabling technologies and support services to create a cohesive offering for medical professionals. The firm’s commercial-stage position allows it to directly engage with hospitals and surgical centers as key customers in the healthcare equipment and supplies sector. Shoulder Innovations Inc's revenue model relies on selling its advanced implant systems, including aTSA and rTSA, alongside InSet Glenoid technology, to hospitals and surgical centers. The company emphasizes procedural efficiency and preoperative planning through its ecosystem, which includes instrument systems and surgeon collaboration tools. By focusing on shoulder arthroplasty, the firm targets a specialized segment within the healthcare market, offering tailored solutions that address both patient requirements and surgical workflow optimization. The company’s products are designed to integrate seamlessly into existing surgical practices, enhancing care delivery across the shoulder surgical care chain. Shoulder Innovations is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shoulder Innovations stock

EV/EBITDA (Enterprise Value to EBITDA) of Shoulder Innovations is -6.08 in 2025.

EV/EBITDA (Enterprise Value to EBITDA) of Shoulder Innovations changed from -21.07 to -6.08, representing a -71.16% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) Shoulder Innovations since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s Shoulder Innovations with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Shoulder Innovations

All Key Metrics — Shoulder Innovations